Leading research and advisory firm, Gartner, recognizes companies in its Cool Vendor report that are interesting, new, and innovative
STAMFORD, Conn.--(BUSINESS WIRE)--#CoolVendors--Sema4, a patient-centered health intelligence company, today announced that it has been named a 2020 Cool Vendor in Healthcare Technology by Gartner Inc., the world’s leading research and advisory company.
According to Gartner’s Cool Vendors in Healthcare Technology report, “healthcare delivery organizations are looking to control cost and respond to industry disruption. The profiled emerging technology and service providers help HDOs make data-driven decisions by leveraging chronic condition management, social determinants of health, virtual care and genetic screening.” Health delivery organizations include entities such as hospitals, doctors’ clinics, and medical specialists’ offices.
Further, “this research identifies five cool vendors that are approaching the market with the right combination of product and business plans, which has lifted them past initial barriers to broader success.” Sema4 is one of the five companies recognized in this report.
“We are honored to be named by Gartner as a Cool Vendor in Healthcare Technology,” said Eric Schadt, PhD, Founder and Chief Executive Officer of Sema4. “By applying artificial intelligence and big data analytics, we are transforming the utility of genomic testing for healthcare providers, and we believe that predictive modeling on large datasets will improve the diagnosis, treatment, and prevention of disease. We believe this recognition from Gartner indicates that our leading-edge work across women’s health, oncology, and biopharma is making a big difference for both healthcare providers and patients.”
Sema4’s recognition in Gartner’s Cool Vendors in Healthcare Technology report further builds on the company’s momentum.
Notable developments over recent months include:
- Sema4 is supporting the virtual patient experience during the COVID-19 outbreak, with the introduction of saliva kits which can be delivered directly to patients for tests such as expanded carrier screening and hereditary cancer;
- Sema4 is performing rapid molecular testing for the detection of SARS-CoV-2, the coronavirus responsible for COVID-19 and is involved in several COVID-19 research programs; and
- Sema4 welcomed Dr. Rachel Sherman to its board of directors, who served most recently as Principal Deputy Commissioner of Food and Drugs, the most senior career position at the FDA.
Gartner subscribers may access the report here.
Gartner, “Cool Vendors in Healthcare Technology,” Anurag Gupta, Lisa Unden-Farbod, Seth Feder, April 28th, 2020.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, express or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Sema4 is a patient-centered health intelligence company founded on the idea that more information, deeper analysis, and increased engagement will improve the diagnosis, treatment, and prevention of disease. Sema4 is dedicated to transforming healthcare by building dynamic models of human health and defining optimal, individualized health trajectories, starting in the areas of reproductive health and oncology. Centrellis™, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.